Wed, Sep 23, 2026
A three-day scientific symposium led by early-career scientists, combining invited talks, selected short talks, poster sessions, workshops, networking, and cross-disciplinary exchange in stem cell and developmental biology.
Wed, Sep 23, 2026
A three-day scientific symposium led by early-career scientists, combining invited talks, selected short talks, poster sessions, workshops, networking, and cross-disciplinary exchange in stem cell and developmental biology.
This Keystone Symposium brings structural and cellular biologists together to integrate cryo-electron microscopy, super-resolution and multiscale imaging, data science, computational modeling and deep learning. The programme connects molecular structure to tissue-level function and includes in-person, livestream and on-demand participation.
Anthony Letai · National Cancer Institute
Mon, Oct 5, 2026 · 16:30 America/New_York
Anthony Letai discusses how understanding programmed cell death can guide the selection of cancer treatments. The seminar explains how apoptotic signalling can be measured and how these measurements can identify drugs capable of killing cancer cells. Hybrid: New Research Building Auditorium, Georgetown University Medical Center, Washington, DC, and Zoom. Monday 5 October 2026, 16:30–17:30 EDT (America/New_York; UTC−4). Use the attendance registration form or the event’s Zoom link on the organizer page. Organized by Georgetown’s Distinguished Scientist Seminar Series. Letai is Director of the National Cancer Institute. An in-person reception follows the seminar.
Tom Nowakowski · Simons Center for the Social Brain at MIT
Wed, Oct 7, 2026 · 16:00 America/New_York
Tom Nowakowski explains lineage barcoding and single-cell sequencing approaches for reconstructing neural stem-cell family trees and early wiring programs in developing mouse and human brains.
Deadline Wed, Sep 23, 2026
The EMBL Imaging Centre is recruiting an application specialist to develop, optimise and deliver super-resolution cryogenic light microscopy and cryo-CLEM workflows, support user projects from experimental design through analysis, and train the wider imaging community.
Deadline Wed, Sep 30, 2026
The Dorrity group at EMBL Heidelberg seeks a Laboratory Officer to investigate gene regulation and cellular identity with single-cell genomics. Work includes mammalian cell culture and engineering, adapting low-input RNA-sequencing protocols, sequencing-library preparation, CRISPR experiments and laboratory training and management. The three-year, full-time position is based on campus. The advert gives a closing date of 30 September 2026 at 23:59 CET.
Deadline Mon, Oct 12, 2026
The EMBL International PhD Programme is accepting applications for its 2027 winter recruitment across EMBL sites. Successful candidates join research groups spanning molecular biology and the life sciences, with virtual assessment followed by in-person interviews.
The Company of Biologists
Deadline Fri, Oct 23, 2026
Graduate students and postdoctoral researchers can seek up to GBP 3,000 for a research visit to another laboratory. Apply to the participating journal that best matches the work: Development, Journal of Cell Science or Journal of Experimental Biology. The next deadline is 23 October 2026 for travel after 7 December 2026. This recurring fellowship supports research collaboration; it is not a training-course bursary.
Matthew J. Girgenti · Yale School of Medicine, Department of Psychiatry
Tue, Oct 13, 2026 · 14:00 America/New_York
Matthew J. Girgenti discusses how research on individual brain cells and the three-dimensional organization of DNA is changing the biological understanding of post-traumatic stress disorder. The seminar examines how these approaches reveal trauma-associated brain changes and identify possible targets for more effective, personalized treatments. Girgenti is a neuroscientist in Yale School of Medicine’s Department of Psychiatry. Jeffrey Borenstein moderates this Meet the Scientist session. Online via the BBRF Zoom webinar. Tuesday 13 October 2026, 14:00 EDT (America/New_York; UTC−4). Follow Register Today on the organizer’s event page to the event-specific Zoom form. Advance registration is available to researchers, students, healthcare providers, mental-health organizations, patients and family members.
Anthony Letai · National Cancer Institute
Mon, Oct 5, 2026 · 16:30 America/New_York
Anthony Letai discusses how understanding programmed cell death can guide the selection of cancer treatments. The seminar explains how apoptotic signalling can be measured and how these measurements can identify drugs capable of killing cancer cells. Hybrid: New Research Building Auditorium, Georgetown University Medical Center, Washington, DC, and Zoom. Monday 5 October 2026, 16:30–17:30 EDT (America/New_York; UTC−4). Use the attendance registration form or the event’s Zoom link on the organizer page. Organized by Georgetown’s Distinguished Scientist Seminar Series. Letai is Director of the National Cancer Institute. An in-person reception follows the seminar.
Yun Xia · A*STAR Institute of Molecular and Cell Biology, Singapore; RIKEN Center for Biosystems Dynamics Research, Japan
Tue, Oct 13, 2026 · 11:00 Asia/Singapore
Yun Xia presents macrophage–kidney assembloids that address missing immune and vascular components in stem-cell organoids. Directed differentiation, self-organization, genetic perturbation, xenotransplantation and single-cell analysis reveal immune–epithelial interactions. Macrophages from the same parental cells acquire resident phenotypes; diabetic and polycystic kidney models show context-dependent effects on inflammation, epithelial injury and disease progression. Minoru Takasato addresses kidney organoids’ missing urinary outflow by generating bladder tissue from human pluripotent cells. Stepwise differentiation passes through endoderm, hindgut and cloaca; FGF4 posteriorization and growth-factor screening promote urothelial identity. The resulting sacs contain stratified urothelial cell types, stretch and form a barrier, supporting developmental, disease and future therapeutic studies. Online via Zoom. Tuesday 13 October, 11:00–12:30 SGT (Asia/Singapore). Both talks share this session; individual start times are unspecified. Register through the organizer page. Professional, trainee or student status in stem cells, regenerative medicine or an adjacent field is required; organizer approval and recording restrictions apply.
Tue, Nov 10, 2026
This EMBO | EMBL Symposium brings cancer researchers together to examine how tumours spread and resist treatment. Topics include circulating and metastasis-initiating cells, invasion, epigenetic regulation, dormancy, cellular plasticity, immune escape and the tumour microenvironment. The programme connects biological mechanisms with imaging, single-cell and spatial profiling, computational analysis and disease models. The event runs from 10 to 13 November 2026 at the EMBL Advanced Training Centre in Heidelberg, with virtual participation available. Abstract submissions are closed. On-site registration closes on 29 September; virtual registration remains available until 3 November. Registration fees and the two booking routes are listed on the organizer page.
We use essential cookies to run the site. Optional analytics and public-page session replay help us improve World Wide. Learn more.